Member Info for bald_eagle

It would be interesting to know what sort of deal they have with CBDerma Tech ltd - but that will be commercially sensitive information. FUM will have a contract with them to provide a certain level of development and presumably CBDerma have agreed to fund (or contribute a certain amount) to that development. We also don't really know who is calling the shots on where the commercialisation is headed. Typically FUM funds development and has full control of the roadmap - which has so far meant trials followed by regulatory submission. The feedback from Mr Barder suggests a change from this model.

We also don't know whether FUM will have full ownership of the IP (I presume they will) and how much money FUM will get in royalties from following the cosmetic skincare route to market. Lots of questions that we may never get the answer to....the only certainty will be increasing revenues at FUM.

Even cosmetic products need to be tested for safety, so some form of trial using real humans must be required...I expect passing quite high amounts of cannabidiol through the skin needs to be investigated for side effects and long term safety (rashes are an obvious concern).

theItalian, I didn't realise you don't have a sense of humour...I thought Italians liked a good joke, Mussolini & Berlosconi good examples. The hemp clothing range should have given it away...with Barders face embroidered on them.

No seriously, I don't think selling cosmetics is going to enhance FUM's credibility as a serious pharma company in the industry....but I suppose beggars cannot be choosers.

So FUM is going to morph into some sort of gimmicky cosmetic company in pursuit of a quick buck...perhaps a sideline of hemp clotheswear with Mr Barder's visage on the front. I suppose they have to pay the bills somehow!!

As others have pointed out, todays RNS hasn't exactly resulted in a trading spree. Circa £30K sells & £25K buys. People aren;t exactly piling into FUM. Perhaps this is a slow burn!!

Jonah, what was your target price?....that it will reach in 10 days. It will be interesting to see how close we get...or exceed!!

BoC, I respect your invetment strategy. You are aware of the risks but hoping for rewards to justify your trust...I have no problems with that, it's called investing after all. I honestly wish you luck.

Cannabidiol seems a bit gimmicky to me (FUM jumping on a bandwagon)....but obviously it could be a lucrative business. The question seems to be can FUM get the active ingredient (cannabidiol) to remain stable & effective for the shelf life of the product in their choice of exipients - the Dermasys ofrmulation required to get it through the skin. Reading between the lines it seems that other companies haven't found this easy.

"Equally worrying is that this rise doesn't seem to be predicated on "public" knowledge... so I wonder who has leaked a forthcoming RNS"
====================================
RB, it could just be speculation. The results are due in September and people could be anticipating they will be positive. The Gold price don't hurt either.

email sent

"NB Antoinette should reply on info@futuramedical.com"
=================================================
Who is Antoinette?
I'm want to contact Tom.

"if it was me would email barder.he is the ceo after all"
=================================
theItalian, I used to email Mr Barder and always had a rapid response. But I believe he no longer deals with investors in the same way & may be using said PR company to filter out the junk.

Ken may be worth trying because I suspect he is calling the shots nowadays anyway....Mr Barder's 'Dominic Cummings' perhaps!!

"info@futuramedical.com
james.barder@futuramedical.com
ken.james@futuramedical.com
investor.relations@futuramedical.com"
======================================================
Volatility, not sure I would send my email to so many 'people'. I suspect they all go to the same PR company FUM employ to filter their external mail anyway.

PS: You forgot Angela's email

"I agree with BE that FUM should come clean on the accidental discovery of MED3000. "
================================================
There is absolutely no reason to pretend that MED3000 was 'a formulation developed specifically for the treatment of ED'...it was found to have positive results for ED purely by accident not by design. There is no shame in admitting the truth. Indeed most scientific advances were found by accident in one way or another....it takes a person of open-minded intelligence to spot something out of the ordinary and investigate. The absurd thing is that EVERYBODY knows the truth and FUM are just making themselves look shifty & untrustworthy...have they been getting advice from Trump on communications as well as deal-making!!

Word of the day: 'fructify'

A keeper!!

"I think that my 108p forecast is way off target. I will revise it to 608p per share"
=========================================================
Joker, another 'cracking' forecast from Fantasy island...good luck with it. Can we expect £6.08 by Christmas?...which Christmas?!

Stability seems to be the hard nut they have to crack...'encouraging' & 'expected' are the highlighted words (IMO) i.e.
- "showing encouraging early stability work"
- "expected to ensure potency is retained during shelf-life"

A bit of a rambling statement from Mr Barder at the end. One sentence (below) seemed to start on the the CBD topic but drift off onto something else at the end....strange.

"We are aiming for CBD100 to be highly differentiated from existing, largely un-regulated, low-tech products in the fast growing cannabidiol market on the basis of quality, stability and efficient delivery to the skin for a number of applications and indications expected to range from cosmeceutical through to pharmaceutical dermal and pain relief treatments. "

theItalian, an excellent idea...one I was already considering. There is nothing like talk of legal action to make a BOD squirm...and miraculously change the wording of their blurb.

The 'problem' for shareholders is to work out what is spin & what is the truth....something IMO that is becoming exceedingly difficult with FUM (since Ken effectively took over the helm).

PS it may not be Ken but he does seem to be in charge now...in all but name.

"Med3000 is a version of Dermasys that was reformulated specifically for the ED application!..."
===========================================
Dosanddonts, is almost correct. Yes, FUM reformulate the base Dermasys for each application, the aim is to maximise the transfer of the active ingredient through the skin barrier. That is correct. But it is the active ingredient that was 'specifically designed' for ED treatment and NOT the base dermasys (since renamed MED3000). It was very clever of someone at FUM (probably Ken) to suggest that it was MED3000 (base dermasys) that was 'specifically designed for ED'....very clever, very sneaky AND 100% unadulterated b0ll0cks!!!
The thing is, the base dermasys was 'designed' to be inert - hence all that GRAS references on their website. Base dermasys was renamed MED3000 and it was designed to be an inert carrier of the active compound. Hence why MED3000 was used as the 'placebo' in the P3 trial. It would have been a bit daft to have a randomized placebo-controlled trial when the placebo being used was actually 'specifically designed' to treat ED. As I say complete 100% b0ll0cks!!
FUM are leaving themselves open to an investor lawsuit for publishing misleading information IMO. And also creating an image - to potential pharma partners - as a company that isn't always truthful. The funny thing is that they don't need to try to fool us. Just stick to the truth FUM

It's obvious....that he believes in daydreams!!

I doubt the FLOTUS needs a prostate examination...she ain't that sort of a lady!!

Joker, you're just a 'daydream believer'.